| Patents for A61P 9 - Drugs for disorders of the cardiovascular system (159,484) |
|---|
| 07/03/2002 | EP1219608A1 Pyrimidine derivatives, process for preparing the derivatives and drugs containing the same as the active ingredient |
| 07/03/2002 | EP1219601A1 Prostaglandin derivatives |
| 07/03/2002 | EP1219600A1 Prostaglandin derivatives |
| 07/03/2002 | EP1218544A1 Methods for identifying rna binding compounds |
| 07/03/2002 | EP1218515A2 Regulation with binding cassette transporter protein abc1 |
| 07/03/2002 | EP1218509A2 Fibroblast growth factor-like polypeptides |
| 07/03/2002 | EP1218491A1 Dna encoding a human subunit 5-ht3-c of the 5-ht3 serotonin receptor |
| 07/03/2002 | EP1218412A2 Human g-protein coupled receptor |
| 07/03/2002 | EP1218408A1 32 human secreted proteins |
| 07/03/2002 | EP1218407A1 Uses of kappa-conotoxin pviia |
| 07/03/2002 | EP1218381A2 AMINO SUBSTITUTED PYRAZOLO 1,5,-a]-1,5-PYRIMIDINES AND PYRAZOLO 1,5-a]-1,3,5-TRIAZINES |
| 07/03/2002 | EP1218379A2 CERTAIN ALKYLENE DIAMINE-SUBSTITUTED PYRAZOLO 1,5,-a]-1,5-PYRIMIDINES AND PYRAZOLO 1,5-a]-1,3,5-TRIAZINES |
| 07/03/2002 | EP1218378A2 Tert.-butyl-(7-methyl-imidazo[1,2-a]pyridine-3-yl)-amine derivatives |
| 07/03/2002 | EP1218376A1 Tyrosine kinase inhibitors |
| 07/03/2002 | EP1218375A1 Pharmaceutically active sulfonyl amino acid derivatives |
| 07/03/2002 | EP1218374A1 Pharmaceutically active sulfonamide derivatives |
| 07/03/2002 | EP1218373A2 2-pyrazolin-5-ones as tyrosine kinase inhibitors |
| 07/03/2002 | EP1218372A1 Novel spiroheterocyclic compounds useful as reversible inhibitors of cysteine proteases |
| 07/03/2002 | EP1218371A2 Di-substituted iminoheterocyclic compounds |
| 07/03/2002 | EP1218369A1 INHIBITORS OF c-JUN N-TERMINAL KINASES (JNK) AND OTHER PROTEIN KINASES |
| 07/03/2002 | EP1218367A1 4-oxybenzopyran derivative |
| 07/03/2002 | EP1218361A1 Oxa- and thiazole derivatives useful as antidiabetic and antiobesity agents |
| 07/03/2002 | EP1218360A1 Triazine kinase inhibitors |
| 07/03/2002 | EP1218358A1 Therapeutic quinazoline compounds |
| 07/03/2002 | EP1218348A2 Indazole compounds and pharmaceutical compositions for inhibiting protein kinases, and methods for their use |
| 07/03/2002 | EP1218347A1 Pyrazoloanthrone and derivatives thereof as jnk inhibitors and their compositions |
| 07/03/2002 | EP1218346A1 Pyrazole derivatives |
| 07/03/2002 | EP1218341A1 Sulfonyl carboxamide derivatives, method for their production and their use as medicaments |
| 07/03/2002 | EP1218335A1 Hydrated n-[3-[[2-(3,4-dimethoxyphenyl)ethyl]amino]propyl]-4-nitro benzamide hydrochloride and it's use in pharmaceutical compositions |
| 07/03/2002 | EP1218334A1 Polymorphic n-[3-[[2-(3,4-dimethoxyphenyl)ethyl]amino]propyl]- 4-nitro benzamide hydrochloride |
| 07/03/2002 | EP1218333A1 Anti-inflammatory nitro- and thia- fatty acids |
| 07/03/2002 | EP1218049A2 Methods and apparatus for relieving headaches, rhinitis and other common ailments |
| 07/03/2002 | EP1218022A2 Composition for the prevention and/or treatment of circulatory disorders, comprising derivatives of l-carnitine and extracts of ginkgo biloba |
| 07/03/2002 | EP1218017A2 Combination of a statin and ex-vivo treated blood for treating atherosclerosis |
| 07/03/2002 | EP1218014A2 Compositions comprising progesterone or progesterone analogs for the treatment of inflammatory conditions |
| 07/03/2002 | EP1218013A2 Phospholipid prodrugs of anti-proliferative drugs |
| 07/03/2002 | EP1218012A2 Use of alprostadil (prostaglandin e1) for producing a medicament for angioneogenesis |
| 07/03/2002 | EP1218005A2 Vitronectin receptor antagonists |
| 07/03/2002 | EP1218001A1 Ultrafine l-carnitine, methods of preparing the same, compositions containing the same, and methods of using the same |
| 07/03/2002 | EP1218000A1 Anti-cancer nitro- and thia-fatty acids |
| 07/03/2002 | EP1217975A1 Using quaternary ammonium salts for transdermal drug delivery |
| 07/03/2002 | EP1217963A1 Devices and methods for treating tissue |
| 07/03/2002 | EP1037871B1 Novel antiarrhythmic compounds |
| 07/03/2002 | EP0754054B1 Antirestenosis protein |
| 07/03/2002 | EP0563345B1 Novel 4-arylpiperazines and 4-arylpiperidines |
| 07/03/2002 | CN1357048A Enhanced prodrug activation |
| 07/03/2002 | CN1357003A 类固醇衍生物 Steroid derivatives |
| 07/03/2002 | CN1357002A Compositions for treating inflammatory response |
| 07/03/2002 | CN1357001A Novel ribose-substituted aromatic amides, method for prodn. and use thereof as medicaments |
| 07/03/2002 | CN1356995A Substituted benzimidazole |
| 07/03/2002 | CN1356991A Quinoline and quinoxaline compounds as PDGF-R and/or LCD tyrosine kinase inhibitors |
| 07/03/2002 | CN1356986A Spiroimidazolidine derivatives, their prepn. their use and pharmaceutical prepns. comprising them |
| 07/03/2002 | CN1356983A Tri-aryl acid derivatives as PPAR receptor ligands |
| 07/03/2002 | CN1356913A Vitronectic receptor antagonist pharmaceuticals |
| 07/03/2002 | CN1356911A Method for treatment of fibrosis using antagonist of integrin alpha-4 subunit |
| 07/03/2002 | CN1356908A Pharmaceutical formulation comprising low molecular weight thrombin inhibitor and its prodrug |
| 07/03/2002 | CN1356907A Fish serine proteinases and their pharmaceutical and cosmetic use |
| 07/03/2002 | CN1356905A Leaves of cajanus cajan(L.) millsp and extract, formulation and uses thereof |
| 07/03/2002 | CN1356902A IL-8 receptor antagonists |
| 07/03/2002 | CN1356899A IL-8 receptor antagonists |
| 07/03/2002 | CN1356338A Separation, synthesis and application in medicine for P6A'S metabolic product |
| 07/03/2002 | CN1356327A Process for extracting flavone from pomelo peel |
| 07/03/2002 | CN1356138A Medicine for treating cardiovascular and cerebrovascular diseases of old people |
| 07/03/2002 | CN1086950C Medicine for treating soft tissue injury |
| 07/02/2002 | US6414157 Compounds having high affinity for 5-ht1b and 5-ht1c serotonin receptor; antidepressants |
| 07/02/2002 | US6414153 1-phenylpydrrolidin-2-ones and -thiones and 1-(4-pyridyl)pydrrolidin-2-ones and -thiones which are useful in the treatment of inflammatory disease |
| 07/02/2002 | US6414151 Process for making 1,3-disubstituted-4-oxocyclic ureas |
| 07/02/2002 | US6414149 Treating diabetes, treating or preventing diabetic complications |
| 07/02/2002 | US6414148 Produce antiangiogenic and/or vascular permeability reducing effect in warm-blooded animals |
| 07/02/2002 | US6414128 Leptin ligand binding; medical diagnosis, therapy, agonists, and antagonists; genetic engineering |
| 07/02/2002 | US6414126 C-aryl glucoside SGLT2 inhibitors and method |
| 07/02/2002 | US6414030 Use of benzenesulfonyl(thio)ureas for the treatment and prophylaxis of dysfunctions of the autonomous nervous system and use of benzenesulfonyl(thio)ureas in combination with beta-receptors blockers |
| 07/02/2002 | US6414026 Compounds which interact with the thyroid hormone receptor for the treatment of fibrotic disease |
| 07/02/2002 | US6414025 Rheumatic disorders; antiinflammatory agents; autoimmune diseases |
| 07/02/2002 | US6414020 Antiproteolytic amidino or derivative useful for treating pencreatitis, thrombosis, ischemia, stroke, restenosis, emphysema or inflammation |
| 07/02/2002 | US6414018 Heart surgery; electricity pacing; administering adrenergic blocking agent |
| 07/02/2002 | US6414013 Thiophene compounds, process for preparing the same, and pharmaceutical compositions containing the same background of the invention |
| 07/02/2002 | US6414012 Heterocyclic derivatives, method of production thereof and pharmaceutical use thereof |
| 07/02/2002 | US6414011 Central nervous system disorders |
| 07/02/2002 | US6414009 Cardiovascular disorders; anticoagulants |
| 07/02/2002 | US6413996 Diaminocyclobutene-3,4-dione derivatives, their preparation and use |
| 07/02/2002 | US6413995 Immunomodulators |
| 07/02/2002 | US6413985 Selective antagonists for the strychnine insensitive glycine binding site associated with the nmda receptor complex. |
| 07/02/2002 | US6413984 8-(heterocyclylmethyl)quinoline derivatives for treating urinary incontinence |
| 07/02/2002 | US6413982 4-substituted quinoline derivatives |
| 07/02/2002 | US6413980 Nitrogen containing heterobicycles as factor Xa inhibitors |
| 07/02/2002 | US6413979 Substituted 5-(2,2-difluoro-1,3-benzodioxol-5-yl) cyclopentenopyridine derivative |
| 07/02/2002 | US6413977 Chromeno[4,3,2-DE]isoquinolines as potent dopamine receptor ligands |
| 07/02/2002 | US6413965 Selective cox-2 and an aldose reductase inhibitor; neuropathy, nephropathy, retinopathy and cardiomyopathy; avoiding side effects such as gastric and renal toxicity |
| 07/02/2002 | US6413964 14-amino-14-(1-methyl-1h-imidazol-5-yl)-8-oxa-2-thia-1,18 -diazatetracyclo(16.2.2.1(3,7).1(9,13))tetracosa-3(24),4,6, 9(23),10,12-hexaene-10-carbonitrile 2,2-dioxide, for example; use in radiotherapy, chemotherapy as sensitizer |
| 07/02/2002 | US6413963 Alpha, beta-integrin inhibitors used in the treatment of multiple sclerosis, atherosclerosis, asthma and inflammatory bowel disease |
| 07/02/2002 | US6413955 1,8-naphthyridines or 5-thio-1,8-naphthyridines or 5-oxo-1,8-naphthyridines; bone resorption, osteoporosis, vascular rest-enosis, diabetic retinopathy, macular degeneration, angio-genesis, atherosclerosis, inflammatory arthritis, cancer |
| 07/02/2002 | US6413943 Methods and reagents for inhibiting proliferation of smooth muscle cells |
| 07/02/2002 | US6413938 Herpes virus |
| 07/02/2002 | US6413936 Glycomimetics as selectin antagonists and pharmaceuticals having antiinflammatory activity |
| 07/02/2002 | US6413756 Isolated human kinase proteins, nucleic acid molecules encoding human kinase proteins, and uses thereof |
| 07/02/2002 | US6413735 Method of screening for a modulator of angiogenesis |
| 07/02/2002 | US6413731 Methods of screening for compounds which bind to a human SNORF36A receptor |
| 07/02/2002 | US6413507 Modified polyether |
| 07/02/2002 | CA2194984C 4-indole derivatives as serotonin agonists and antagonists |